COVID-19 Convalescent Plasma Trials

UPenn’s Katharine Bar discusses ongoing clinical trials to explore the efficacy of treating patients with plasma from individuals who have recovered from an infection.

The Scientist Staff

Aug 18, 2020

Read the full story.

Related Articles

SARS-CoV-2 with Genomic Deletions Escapes an Antibody

SARS-CoV-2 with Genomic Deletions Escapes an Antibody

SARS-CoV-2 with Genomic Deletions Escapes an Antibody

Vaccines Versus the Mutants

Vaccines Versus the Mutants

Vaccines Versus the Mutants

What’s Ahead for SARS-CoV-2 Research in 2021

What’s Ahead for SARS-CoV-2 Research in 2021

What’s Ahead for SARS-CoV-2 Research in 2021

Opinion: Emergency Use Authorizations Are a Threat to Science<strong> </strong>

Opinion: Emergency Use Authorizations Are a Threat to Science

Opinion: Emergency Use Authorizations Are a Threat to Science